Emetic embedded capsule
View Patent ↗This invention provides capsules containing an emetic, which capsules can encapsulate a drug, wherein the amount of emetic and the amount of drug is such that the number of capsules needed to be ingested to cause emesis is fewer than the number of capsules needed to be ingested to cause overdose of the drug, so that if a person takes an overdose of the emetic encapsulated drug, he or she will vomit before the drug is absorbed by the body.
1. A hard capsule piece for encapsulating a drug, wherein the hard capsule piece comprises:
an emetic;
a matrix; and
a plasticizer; and
wherein said emetic is embedded in the hard capsule piece.
2. The hard capsule piece of claim 1 , further comprising an inert material.
3. The hard capsule piece of claim 1 , wherein said matrix and said plasticizer form a shell having a discrete compartment, said emetic being contained within the compartment, said shell capable of engaging a second capsule piece.
4. The hard capsule piece of claim 1 formed from an admixture of the matrix, the plasticizer, and the emetic.
5. The hard capsule according to claim 1 , wherein the capsule comprises a first capsule piece and a second capsule piece cooperatively engaging for encapsulating a drug.
6. The hard capsule of claim 5 , which encapsulates a unit dosage of a drug, wherein the weight of the emetic is in the range of 1/X to 1/Y of an emetic dose to induce emesis, with X being the number of unit dosages of the drug prescribed for administration within a particular time period and Y being the number of unit dosages of the drug which would constitute an overdose if taken in the same time period.
7. The hard capsule of claim 5 wherein the emetic is selected from the group consisting of central emetics and gastric emetics.
8. The hard capsule of claim 5 wherein the emetic is selected from the group consisting of emetine, methyl cephaeline, cephaeline, emetine hydrochloride, psychotrine, O-methylpsychotrine, emetamine, ipecamine, hydro-ipecamine, ipecacunhun acid, apomorphine, ammonium carbonate, cupric sulfate, tartar emetic, zinc sulfate, blacks mustard, sanguinaria, copper sulfate, eucalyptole, eucalyptus oil, glycynhiza, guaiacol, lobelia, potassium iodide, senega terebene, terpin hydrate, thyme, caffeine, lobelia inflata, and sodium bicarbonate salt, and combinations thereof.
9. A hard capsule according to claim 5 , wherein the hard capsule piece further comprises a drug, and wherein the amount of emetic and the amount of the drug is such that the number of capsules needed to be ingested to cause emesis is fewer than the number of capsules needed to be ingested to cause overdose of said drug.
10. The hard capsule piece according to claim 9 wherein the drug is a drug which can cause death or serious injury to a human at a level of 50 or fewer times the recommended dosage.
11. The hard capsule piece of claim 9 wherein the drug is selected from the group consisting of acetylsalicylic acid, acetaminophen, vitamins, psychotropics, anti-hypertensitive, anti-seizures, amphetamines, anti-microbials, antibiotics, anti-virals, anti-retrovirals, anti-fungals, anti-depressants, stimulants, anti-histamines, anti-anxiety, tranquilizers, benzodiazepines, hypnotics, mood stabilizers, codeine, selective serotonin reuptake inhibitors, anti-allergy, phenothiazine, chemotherapeutics, amines, monoamine oxidase inhibitors, anti-carcinogens, analgesics, muscle relaxants, ergot preparations, anti-cholinergic, anti-inflammatory, anti-gout preparations, soporfic, hormonal preparations, appetite suppressants, analgesics, muscle relaxants, and opioids, and combinations thereof.
12. The hard capsule piece according to claim 11 wherein the drug is codeine.
13. The hard capsule piece according to claim 11 wherein the drug is an anti-depressant.
14. The hard capsule piece according to claim 11 wherein the drug is an opioid.
15. The hard capsule piece according to claim 11 wherein the drug is an analgesic.
16. The hard capsule piece according to claim 11 wherein the drug is an antipsychotic.
17. The hard capsule piece according to claim 9 wherein the emetic is any substance capable of inducing emesis.
18. The hard capsule piece according to claim 17 wherein the emetic is selected from the group consisting of emetine, methyl cephaeline, cephaeline, emetine hydrochloride, psychotrine, O-methylpsychotrine, emetamine, ipecamine, hydro-ipecamine, ipecacunhun acid, apomorphine, ammonium carbonate, cupric sulfate, tartar emetic, zinc sulfate, blacks mustard, sanguinaria, copper sulfate, eucalyptole, eucalyptus oil, glycynhiza, guaiacol, lobelia, potassium iodide, senega terebene, terpin hydrate, thyme, caffeine, and sodium bicarbonate salt, and combinations thereof.
19. A method of preventing or reducing the risk of a drug overdose comprising encapsulating a drug in the hard capsule according to claim 5 such that ingesting of a proper amount of drug does not induce emesis, but ingestion of excess drug induces emesis.
20. A method of preventing or reducing the risk of overdose of a drug administered to a patient considered to be at risk of accidentally or deliberately taking an overdose of the drug, comprising encapsulating the drug in the hard capsule according to claim 5 such that ingesting of a proper amount of the drug does not induce emesis, but ingestion of excess drug induces emesis.
21. The hard capsule piece according to claim 3 , wherein the capsule comprises a first capsule piece and a second capsule piece cooperatively engaging for encapsulating a drug.
22. The hard capsule piece according to claim 4 , wherein the capsule comprises a first capsule piece and a second capsule piece cooperatively engaging for encapsulating a drug.